{"transactions":[{"id":714367,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-06T20:14:34.000Z","date":"2026-07-01","kind":"purchase","planned":true,"acquired":true,"shares":1736,"price":19.05,"value":33070.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025."}],"balance_after":80737,"source":{"system":"sec-edgar","filing":"0000905148-26-003169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514826003169/form4.xml","form_type":"4"}},{"id":729998,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-06-22T20:08:23.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":22371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 17, 2027, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":79001,"source":{"system":"sec-edgar","filing":"0000905148-26-003032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514826003032/form4.xml","form_type":"4"}},{"id":765457,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T23:59:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000087","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000087/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765456,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T23:59:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000087","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000087/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765455,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765454,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."}],"balance_after":5409,"derivative":{"exercise_date":"2027-05-20","underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765453,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the stock option award vest and become exercisable in full on 5/20/2027."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765452,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":35751,"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765451,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":37226,"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":833128,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-03-19T20:05:38.000Z","date":"2026-03-17","kind":"purchase","planned":true,"acquired":true,"shares":1731,"price":18.91,"value":32733.21,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025."}],"balance_after":56630,"source":{"system":"sec-edgar","filing":"0000905148-26-001398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514826001398/form4.xml","form_type":"4"}},{"id":1103420,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2025-06-23T20:11:09.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":10831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 18, 2026, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":54899,"source":{"system":"sec-edgar","filing":"0000905148-25-002217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514825002217/form4.xml","form_type":"4"}},{"id":1127260,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-06-02T20:29:39.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":false,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001127602-25-016198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225016198/form4.xml","form_type":"4"}},{"id":1127259,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-06-02T20:29:39.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1924,"price":30.61,"value":58893.64,"ownership":{"direct":true},"balance_after":31084,"source":{"system":"sec-edgar","filing":"0001127602-25-016198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225016198/form4.xml","form_type":"4"}},{"id":1127258,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-06-02T20:29:39.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":true,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":33008,"source":{"system":"sec-edgar","filing":"0001127602-25-016198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225016198/form4.xml","form_type":"4"}},{"id":1134837,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-05-23T21:56:13.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":6142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/21/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/21/2026."}],"balance_after":6142,"derivative":{"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001127602-25-015539","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225015539/form4.xml","form_type":"4"}},{"id":1134836,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2025-05-23T21:56:13.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":13474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 5/21/2026."}],"balance_after":13474,"derivative":{"exercise_price":30.53,"exercise_date":"2026-05-21","expiration_date":"2035-05-21","underlying":"Ordinary Shares","underlying_shares":13474},"source":{"system":"sec-edgar","filing":"0001127602-25-015539","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225015539/form4.xml","form_type":"4"}},{"id":1218958,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2025-03-06T21:21:24.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":35.07,"value":87675.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024."}],"balance_after":44068,"source":{"system":"sec-edgar","filing":"0000905148-25-000873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514825000873/form4.xml","form_type":"4"}},{"id":1413462,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2024-09-05T20:13:20.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":19.5,"value":48750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024."}],"balance_after":46568,"source":{"system":"sec-edgar","filing":"0000905148-24-002519","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824002519/form4.xml","form_type":"4"}},{"id":1465520,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-07-01T20:55:57.000Z","date":"2024-06-29","kind":"exercise","planned":false,"acquired":false,"shares":6104,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-24-019594","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224019594/form4.xml","form_type":"4"}},{"id":1465519,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2024-07-01T20:55:57.000Z","date":"2024-06-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1465,"price":24.1,"value":35306.5,"ownership":{"direct":true},"balance_after":24995,"source":{"system":"sec-edgar","filing":"0001127602-24-019594","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224019594/form4.xml","form_type":"4"}},{"id":1465518,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2024-07-01T20:55:57.000Z","date":"2024-06-29","kind":"exercise","planned":false,"acquired":true,"shares":6104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":26460,"source":{"system":"sec-edgar","filing":"0001127602-24-019594","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224019594/form4.xml","form_type":"4"}},{"id":1472737,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:01:30.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":21253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 18, 2025, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":49068,"source":{"system":"sec-edgar","filing":"0000905148-24-001753","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001753/form4.xml","form_type":"4"}},{"id":1491552,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":17492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares subject to the stock option award vest and become exercisable in full on 5/31/2025."}],"balance_after":17492,"derivative":{"exercise_price":23.4,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Ordinary Shares","underlying_shares":17492},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491551,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-06-04T20:53:00.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":8013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the restricted stock unit award vest in full on 5/31/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares subject to the restricted stock unit award vest in full on 5/31/2025."}],"balance_after":8013,"derivative":{"exercise_date":"2025-05-31","underlying":"Ordinary Shares","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491550,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":119,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."}],"balance_after":6104,"derivative":{"exercise_date":"2024-06-29","underlying":"Ordinary Shares","underlying_shares":119},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491549,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":254,"price":30.72,"value":7802.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest and become exercisable in full on 6/29/2024."}],"balance_after":12986,"derivative":{"exercise_price":30.72,"exercise_date":"2024-06-29","expiration_date":"2033-06-29","underlying":"Ordinary Shares","underlying_shares":254},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491548,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":231,"price":30.86,"value":7128.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":11785,"derivative":{"exercise_price":30.86,"expiration_date":"2032-07-07","underlying":"Ordinary Shares","underlying_shares":231},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491547,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":313,"price":24.24,"value":7587.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":15990,"derivative":{"exercise_price":24.24,"expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491546,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":230,"price":18.45,"value":4243.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":11739,"derivative":{"exercise_price":18.45,"expiration_date":"2030-12-02","underlying":"Ordinary Shares","underlying_shares":230},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491545,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":256,"price":16.52,"value":4229.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":13079,"derivative":{"exercise_price":16.52,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":256},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491544,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":224,"price":20.81,"value":4661.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":11424,"derivative":{"exercise_price":20.81,"expiration_date":"2029-12-04","underlying":"Ordinary Shares","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1491543,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:53:00.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":1236,"price":20.81,"value":25721.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":63036,"derivative":{"exercise_price":20.81,"expiration_date":"2029-12-04","underlying":"Ordinary Shares","underlying_shares":1236},"source":{"system":"sec-edgar","filing":"0001127602-24-017725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017725/form4.xml","form_type":"4"}},{"id":1832098,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2023-07-11T00:30:59.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":5957,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5957},"source":{"system":"sec-edgar","filing":"0001127602-23-020547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223020547/form4.xml","form_type":"4"}},{"id":1832097,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-07-11T00:30:59.000Z","date":"2023-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1430,"price":29.88,"value":42728.4,"ownership":{"direct":true},"balance_after":20356,"source":{"system":"sec-edgar","filing":"0001127602-23-020547","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223020547/form4.xml","form_type":"4"}},{"id":1832096,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-07-11T00:30:59.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":5957,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":21786,"source":{"system":"sec-edgar","filing":"0001127602-23-020547","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223020547/form4.xml","form_type":"4"}},{"id":1840856,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2023-06-30T20:33:39.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":5985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."}],"balance_after":5985,"derivative":{"exercise_date":"2024-06-29","underlying":"Ordinary Shares","underlying_shares":5985},"source":{"system":"sec-edgar","filing":"0001127602-23-019628","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223019628/form4.xml","form_type":"4"}},{"id":1840855,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2023-06-30T20:33:39.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":12732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 6/29/2024."}],"balance_after":12732,"derivative":{"exercise_price":31.33,"exercise_date":"2024-06-29","expiration_date":"2033-06-29","underlying":"Ordinary Shares","underlying_shares":12732},"source":{"system":"sec-edgar","filing":"0001127602-23-019628","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223019628/form4.xml","form_type":"4"}},{"id":1840785,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2023-06-30T20:05:47.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":18903,"price":26.45,"value":499984.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":27815,"source":{"system":"sec-edgar","filing":"0000950170-23-031095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000095017023031095/ownership.xml","form_type":"4"}},{"id":2209681,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2022-07-08T20:19:29.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":11554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest and become exercisable in full on 7/7/2023."}],"balance_after":11554,"derivative":{"exercise_price":31.48,"exercise_date":"2023-07-07","expiration_date":"2032-07-07","underlying":"Ordinary Shares","underlying_shares":11554},"source":{"system":"sec-edgar","filing":"0001127602-22-019127","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222019127/form4.xml","form_type":"4"}},{"id":2209680,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2022-07-08T20:19:29.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":5957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 7/7/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 7/7/2023."}],"balance_after":5957,"derivative":{"exercise_date":"2023-07-07","underlying":"Ordinary Shares","underlying_shares":5957},"source":{"system":"sec-edgar","filing":"0001127602-22-019127","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222019127/form4.xml","form_type":"4"}},{"id":2229584,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2022-06-16T20:57:14.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":7585,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7585},"source":{"system":"sec-edgar","filing":"0001127602-22-017637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222017637/form4.xml","form_type":"4"}},{"id":2229583,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-06-16T20:57:14.000Z","date":"2022-06-14","kind":"tax_withholding","acquired":false,"shares":695,"price":27.19,"value":18897.05,"ownership":{"direct":true},"balance_after":15829,"source":{"system":"sec-edgar","filing":"0001127602-22-017637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222017637/form4.xml","form_type":"4"}},{"id":2229582,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-06-16T20:57:14.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":7585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":16524,"source":{"system":"sec-edgar","filing":"0001127602-22-017637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222017637/form4.xml","form_type":"4"}},{"id":2230370,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Stock Option(right to buy)","published_at":"2022-06-16T20:43:00.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.679,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001140361-22-023319","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000114036122023319/form4.xml","form_type":"4"}},{"id":2485098,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-12-04T02:24:43.000Z","date":"2021-12-02","kind":"exercise","acquired":false,"shares":5578,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5578},"source":{"system":"sec-edgar","filing":"0001127602-21-030302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221030302/form4.xml","form_type":"4"}},{"id":2485097,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-12-04T02:24:43.000Z","date":"2021-12-02","kind":"tax_withholding","acquired":false,"shares":1339,"price":22.11,"value":29605.29,"ownership":{"direct":true},"balance_after":8939,"source":{"system":"sec-edgar","filing":"0001127602-21-030302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221030302/form4.xml","form_type":"4"}},{"id":2485096,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-12-04T02:24:43.000Z","date":"2021-12-02","kind":"exercise","acquired":true,"shares":5578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":10278,"source":{"system":"sec-edgar","filing":"0001127602-21-030302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221030302/form4.xml","form_type":"4"}},{"id":2500002,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-11-22T12:40:39.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":8912,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8912,"source":{"system":"sec-edgar","filing":"0000899243-21-045487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924321045487/doc4.xml","form_type":"4"}},{"id":2665693,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-06-16T20:26:49.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":7585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/14/2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/14/2022."}],"balance_after":7585,"derivative":{"exercise_date":"2022-06-14","underlying":"Ordinary Shares","underlying_shares":7585},"source":{"system":"sec-edgar","filing":"0001127602-21-020043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221020043/form4.xml","form_type":"4"}},{"id":2665692,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-06-16T20:26:49.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":15677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 6/14/2022."}],"balance_after":15677,"derivative":{"exercise_price":24.72,"exercise_date":"2022-06-14","expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":15677},"source":{"system":"sec-edgar","filing":"0001127602-21-020043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221020043/form4.xml","form_type":"4"}},{"id":2672442,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T16:15:53.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-21-020645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000114036121020645/form4.xml","form_type":"4"}},{"id":2700391,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-05-21T20:35:42.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This restricted stock unit award vested in full on 5/20/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This restricted stock unit award vested in full on 5/20/2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-21-017788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221017788/form4.xml","form_type":"4"}},{"id":2700390,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-05-21T20:35:42.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":1404,"price":21.92,"value":30775.68,"ownership":{"direct":true},"balance_after":4700,"source":{"system":"sec-edgar","filing":"0001127602-21-017788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221017788/form4.xml","form_type":"4"}},{"id":2700389,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-05-21T20:35:42.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6104,"source":{"system":"sec-edgar","filing":"0001127602-21-017788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221017788/form4.xml","form_type":"4"}},{"id":2956291,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2020-12-04T21:33:18.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":5578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/2/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/2/2021."}],"balance_after":5578,"derivative":{"exercise_price":0,"exercise_date":"2021-12-02","underlying":"Ordinary Shares","underlying_shares":5578},"source":{"system":"sec-edgar","filing":"0001127602-20-030576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760220030576/form4.xml","form_type":"4"}},{"id":2956290,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2020-12-04T21:33:18.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":11509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option becomes exercisable in full on 12/2/2021."}],"balance_after":11509,"derivative":{"exercise_price":18.82,"exercise_date":"2021-12-02","expiration_date":"2030-12-02","underlying":"Ordinary Shares","underlying_shares":11509},"source":{"system":"sec-edgar","filing":"0001127602-20-030576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760220030576/form4.xml","form_type":"4"}},{"id":3136631,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2020-05-22T20:21:55.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2021."}],"balance_after":6104,"derivative":{"exercise_price":0,"exercise_date":"2021-05-20","underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-20-017769","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760220017769/form4.xml","form_type":"4"}},{"id":3136630,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2020-05-22T20:21:55.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":12823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option becomes exercisable in full on 5/20/2021."}],"balance_after":12823,"derivative":{"exercise_price":16.85,"exercise_date":"2021-05-20","expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":12823},"source":{"system":"sec-edgar","filing":"0001127602-20-017769","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760220017769/form4.xml","form_type":"4"}},{"id":3159634,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:06:48.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":155373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option which was outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) was cancelled and converted automatically into the right to receive, as soon as reasonably practicable after the Effective Time (but no later than ten business days thereafter), a cash payment in an amount equal to the product of (i) the total number of Shares subject to such option immediately prior to such cancellation and (ii) the excess, if any, of the Cash Merger Consideration over the exercise price per Share subject to such option immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option which was outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) was cancelled and converted automatically into the right to receive, as soon as reasonably practicable after the Effective Time (but no later than ten business days thereafter), a cash payment in an amount equal to the product of (i) the total number of Shares subject to such option immediately prior to such cancellation and (ii) the excess, if any, of the Cash Merger Consideration over the exercise price per Share subject to such option immediately prior to such cancellation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option which was outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) was cancelled and converted automatically into the right to receive, as soon as reasonably practicable after the Effective Time (but no later than ten business days thereafter), a cash payment in an amount equal to the product of (i) the total number of Shares subject to such option immediately prior to such cancellation and (ii) the excess, if any, of the Cash Merger Consideration over the exercise price per Share subject to such option immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":2.65,"underlying":"Common Stock","underlying_shares":155373},"source":{"system":"sec-edgar","filing":"0001694187-20-000065","document":"wf-form4_158881359090519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000065/wf-form4_158881359090519.xml","form_type":"4"}},{"id":3159633,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:06:48.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":105000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":6.13,"underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001694187-20-000065","document":"wf-form4_158881359090519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000065/wf-form4_158881359090519.xml","form_type":"4"}},{"id":3159632,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:06:48.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":58005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":10.2,"underlying":"Common Stock","underlying_shares":58005},"source":{"system":"sec-edgar","filing":"0001694187-20-000065","document":"wf-form4_158881359090519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000065/wf-form4_158881359090519.xml","form_type":"4"}},{"id":3159631,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2020-05-06T21:06:48.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":210410,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE (\"BioNTech\"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of May 6, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive 0.063 (the \"Exchange Ratio\") of American Depositary Shares of BioNTech (\"BioNTech ADS\") plus the right, if any, to receive cash in lieu of fractional shares of BioNTech ADSs into which such Shares would have been converted. This number includes 159,584 restricted stock units (each, an \"RSU\") held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE (\"BioNTech\"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of May 6, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive 0.063 (the \"Exchange Ratio\") of American Depositary Shares of BioNTech (\"BioNTech ADS\") plus the right, if any, to receive cash in lieu of fractional shares of BioNTech ADSs into which such Shares would have been converted. This number includes 159,584 restricted stock units (each, an \"RSU\") held by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001694187-20-000065","document":"wf-form4_158881359090519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000065/wf-form4_158881359090519.xml","form_type":"4"}},{"id":3205954,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-17T16:34:06.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing sale price per share of the Issuer's common stock as reported on the Nasdaq Global Select Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/8th of the shares on March 31, 2020 and as to 1/8th of the shares at the end of each calendar quarter thereafter, provided that the holder continues to serve as a director of the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":0.685,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-008613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924320008613/doc4.xml","form_type":"4"}},{"id":3238362,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2020-03-02T18:39:22.000Z","date":"2020-02-29","kind":"tax_withholding","acquired":false,"shares":5625,"price":1.5,"value":8437.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent shares withheld to satisfy tax obligations arising from the vesting of restricted stock units awarded to the reporting person on February 27, 2019 and do not represent a discretionary trade by the reporting person. The number of shares to be withheld was determinable on February 29, 2020."}],"balance_after":210410,"source":{"system":"sec-edgar","filing":"0001694187-20-000029","document":"wf-form4_158319234594040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000029/wf-form4_158319234594040.xml","form_type":"4"}},{"id":3243996,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2020-02-27T18:21:00.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":5465,"price":1.51,"value":8252.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent shares withheld to satisfy tax obligations arising from the vesting of restricted stock units awarded to the reporting person on November 25, 2019 and do not represent a discretionary trade by the reporting person. The number of shares to be withheld was determinable on February 25, 2020."}],"balance_after":216035,"source":{"system":"sec-edgar","filing":"0001694187-20-000012","document":"wf-form4_158284564352844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000012/wf-form4_158284564352844.xml","form_type":"4"}},{"id":3312690,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2020-01-13T17:01:04.000Z","date":"2020-01-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Gaynor was awarded 65,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. The Restricted Stock Units shall vest annually over three years, with one-third vesting on January 31, 2021 and the balance vesting in two equal annual installments thereafter, subject to the Reporting Person's continued service. The Restricted Stock Units may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":221500,"source":{"system":"sec-edgar","filing":"0001694187-20-000006","document":"wf-form4_157895284328015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000006/wf-form4_157895284328015.xml","form_type":"4"}},{"id":3347816,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2019-12-09T21:11:56.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":61800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Late filing due to administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 3 equal annual installments commencing on 12/4/2020."}],"balance_after":61800,"derivative":{"exercise_price":21.23,"exercise_date":"2020-12-04","expiration_date":"2029-12-04","underlying":"Ordinary Shares","underlying_shares":61800},"source":{"system":"sec-edgar","filing":"0001127602-19-034549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760219034549/form4.xml","form_type":"4"}},{"id":3347815,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2019-12-09T21:11:56.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":11200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Late filing due to administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option becomes exercisable in full on 12/4/2020."}],"balance_after":11200,"derivative":{"exercise_price":21.23,"exercise_date":"2020-12-04","expiration_date":"2029-12-04","underlying":"Ordinary Shares","underlying_shares":11200},"source":{"system":"sec-edgar","filing":"0001127602-19-034549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760219034549/form4.xml","form_type":"4"}},{"id":3357703,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2019-11-27T17:01:58.000Z","date":"2019-11-27","kind":"sale","acquired":false,"shares":22322,"price":1.2384,"value":27643.5648,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.18 to $1.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":156500,"source":{"system":"sec-edgar","filing":"0001694187-19-000080","document":"wf-form4_157489210160884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000080/wf-form4_157489210160884.xml","form_type":"4"}},{"id":3357702,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2019-11-27T17:01:58.000Z","date":"2019-11-26","kind":"sale","acquired":false,"shares":23000,"price":1.3144,"value":30231.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":178822,"source":{"system":"sec-edgar","filing":"0001694187-19-000080","document":"wf-form4_157489210160884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000080/wf-form4_157489210160884.xml","form_type":"4"}},{"id":3357701,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2019-11-27T17:01:58.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":20000,"price":1.3749,"value":27498.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.36 to $1.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":201822,"source":{"system":"sec-edgar","filing":"0001694187-19-000080","document":"wf-form4_157489210160884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000080/wf-form4_157489210160884.xml","form_type":"4"}},{"id":3360057,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2019-11-25T17:25:06.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Gaynor was awarded 75,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. The Restricted Stock Units shall vest quarterly over one year, subject to the Reporting Person's continued service, with the first tranche vesting on February 25, 2020. The Restricted Stock Units may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":221822,"source":{"system":"sec-edgar","filing":"0001694187-19-000077","document":"wf-form4_157472068909037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000077/wf-form4_157472068909037.xml","form_type":"4"}},{"id":3623344,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2019-03-01T18:19:19.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in equal monthly installments over four years commencing on February 27, 2019."}],"balance_after":105000,"derivative":{"exercise_price":6.13,"expiration_date":"2029-02-26","underlying":"Stock Option (Right to Buy)","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001694187-19-000013","document":"wf-form4_155148234493134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000013/wf-form4_155148234493134.xml","form_type":"4"}},{"id":3623343,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2019-03-01T18:19:19.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Gaynor was awarded 57,500 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. The Restricted Stock Units shall vest annually over three years, with one-third vesting on the last day of February 2020 and the balance vesting in two equal annual installments thereafter, subject to the Reporting Person's continued service. The Restricted Stock Units may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":146822,"source":{"system":"sec-edgar","filing":"0001694187-19-000013","document":"wf-form4_155148234493134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000013/wf-form4_155148234493134.xml","form_type":"4"}}]}